News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


PHARMAC funds two more heart drugs

PHARMAC is to subsidise two more drugs to help fight heart disease after reaching an innovative agreement with the drugs’ supplier, AstraZeneca.

PHARMAC is to fund a new, expensive blood pressure lowering drug called candesartan, which may be valuable for patients whose blood pressure is not adequately controlled on other drugs. The drug is significantly more expensive than the current options available.

As well, PHARMAC has agreed to subsidise a new low dose beta-blocker called metoprolol succinate. According to new evidence it may give another treatment option for some people with heart failure.

The funding of the drug has been made possible as part of a package where AstraZeneca has dropped the price of one of its older blood pressure treatments, felodipine, which belongs to a class of drugs known as DHP CCBs.

PHARMAC General Manager Wayne McNee says the AstraZeneca agreement is a good example of how a co-operative environment can help all parties, with patients in particular getting the benefit.

“By freeing up funding in one area, we are able to invest in new drugs which will give prescribers more tools in their arsenal to fight cardiovascular disease.”

He says the company will be working with PHARMAC to ensure that candesarten is used appropriately. Under a risk sharing arrangement, the company will have to pay PHARMAC back if the drug is over-used.

Candesarten will be fully subsidised from December 1. Low dose metoprolol will be available after it obtains approval from the Ministry of Health.


For further information contact PHARMAC General Manager Wayne McNee.
Phone: (025) 429-212.

© Scoop Media

Culture Headlines | Health Headlines | Education Headlines


Scoop Review Of Books Q&A: Historian Vincent O’Malley

There is quite a lot of ignorance of the basic facts of New Zealand history because so few people learn anything about it at school and that is fully evident whenever anything on these issues is published in the media, such as Stuff’s wonderful recent series about the Treaty... More>>

Howard Davis: NZSO Perform Beethoven's Symphonies 1 & 9 This Weekend

When we consider how prodigious Beethoven's musical output was - including nine symphonies, five piano concertos, a violin concerto, various piano sonatas, sixteen string quartets, a mass, and an opera - it is a truly remarkable achievement that only twenty-four years separated the premieres of his first and final symphonies. More>>

2021: NZ To Host Women’s Rugby World Cup

New Zealand’s successful bid to host the 2021 Women’s Rugby World Cup will raise the profile of the game locally and provide a valuable economic boost for the game, Minister for Sport and Recreation Grant Robertson says. More>>


Max Rashbrooke Review: Mahler 7 - NZSO

Gustav Mahler’s Seventh Symphony may be one of the least well-known of its ilk, but Edo de Waart and the New Zealand Symphony Orchestra made a compelling case for a reassessment. They showed us a work of immense variety, surprising contrast and delicate shades of light and dark. More>>



  • Wellington
  • Christchurch
  • Auckland